Sustainability is both a top priority and significant challenge as the clinical research industry aims to minimise their environmental impact and get meaningful therapies to patients. Read about the trends, challenges and future of sustainability in clinical development in our latest article: https://ow.ly/w3pC50UnfT9
ICON Government and Public Health Solutions
Biotechnology Research
Blue Bell, Pennsylvania 4,175 followers
Serving US Federal and NGO Clients
About us
ICON Government and Public Health Solutions, ICON GPHS provides full-service clinical development and staffing services across multiple agencies in the US Government and is a trusted partner to both multinational public health organizations, and global Non-Government Organizations (NGOs). Our clinical development expertise extends across basic and applied research, manufacturing, infectious and neglected tropical diseases, oncology, vaccines development and testing, and the response to bio-threats.
- Website
-
http://www.iconplc.com/gphs
External link for ICON Government and Public Health Solutions
- Industry
- Biotechnology Research
- Company size
- 201-500 employees
- Headquarters
- Blue Bell, Pennsylvania
- Type
- Public Company
- Founded
- 1994
- Specialties
- research, clinical, staffing, government, public health, and CRO
Locations
-
Primary
731 Arbor Way
Suite 100
Blue Bell, Pennsylvania 19422, US
Employees at ICON Government and Public Health Solutions
-
Robert Spitz
Medical Director at ICON Government and Public Health Solutions
-
Matthew Algeri
Project Control Manager at ICON Government & Public Health Solutions
-
Jeremy Somers
Contract Manager at ICON Government and Public Health Solutions
-
Claire Holland
Director, Proposal Management at ICON Government and Public Health Solutions
Updates
-
Educate. Advocate. Act now. is the theme for this year’s AMR global campaign. According to World Health Organization, AMR occurs when bacteria and viruses no longer respond to antimicrobial agents. As a result of drug resistance, antibiotics and other antimicrobial agents become ineffective and infections become difficult or impossible to treat, increasing the risk of disease spread, severe illness and death. https://ow.ly/7Cwg50U8XNX #WAAW =#PreventingAntimicrobialResistanceTogether
-
Antimicrobial resistance (AMR) is a pressing global health and socioeconomic crisis. In the past 5 years, ICON has participated in 432 infectious disease clinical studies enrolling 461,800+ patients and healthy volunteers (HVs) at 10,500+ sites. https://ow.ly/AbW750U8XKR #WAAW
-
Unlock the power of full-service clinical development and staffing with ICON Government and Public Health Solutions. As a preferred partner of BARDA and trusted by global health organisations, our expertise spans basic and applied research, manufacturing, infectious and neglected tropical diseases, oncology, vaccine development, and bio-threat response. With over 20 years of experience in Africa, conducting trials with over 10,000 patients across 27 African and Middle East countries, partner with us to advance public health and safety. https://lnkd.in/ezXK9_DU
-
Unlock the power of full-service clinical development and staffing with ICON Government and Public Health Solutions. As a preferred partner of BARDA and trusted by global health organisations, our expertise spans basic and applied research, manufacturing, infectious and neglected tropical diseases, oncology, vaccine development, and bio-threat response. With over 20 years of experience in Africa, conducting trials with over 10,000 patients across 27 African and Middle East countries, partner with us to advance public health and safety. https://lnkd.in/ezXK9_DU
-
Leverage the industry's most experienced reader network of cardiovascular (CV) physicians and experts who will help you navigate the latest changes in cardiac safety trial requirements. Find out how we can help you: https://ow.ly/IwBQ50T8zez
-
ICON Government and Public Health Solutions is your go-to partner for full-service clinical development and staffing. Our proven track record with global health entities ensures unparalleled support in infectious diseases, oncology, vaccine development, and bio-threat response. Join us in our mission to protect and improve public health worldwide. Discover our latest thought leadership. https://lnkd.in/ezXK9_DU
-
Unlock the power of full-service clinical development and staffing with ICON Government and Public Health Solutions. As a trusted partner of global health organisations, we are committed to saving lives and improving global health. Our expertise spans basic and applied research, manufacturing, infectious and neglected tropical diseases, oncology, vaccine development, and bio-threat response. Partner with us to advance public health and safety. Discover more about our mission and services. https://lnkd.in/ezXK9_DU
-
A droplet digital polymerase chain reaction (ddPCR) test was recently developed and validated by ICON to evaluate the ratio of unmethylated to total target sequence (U/U+M) in ccfDNA isolated from K2EDTA whole blood (WB/K2EDTA) plasma. Read more about how this validated ddPCR test is used to monitor the death of target gene expressing CDP in patient samples. https://ow.ly/XCrF50T8mPu
-
Elevate your clinical development and meet your staffing needs with ICON Government and Public Health Solutions. We bring expertise in more than 27 African countries, partnering with leading public health organisations to deliver comprehensive services in research, manufacturing, oncology, vaccine development, and more. Trust our experienced team to support your mission in safeguarding public health. Learn more about our commitment and capabilities. https://lnkd.in/ezXK9_DU